USING DERIVATIVES OF (-)-(3-TRIHALOMETHYLPHENOXY)-(4-HALOPHENYL)-ACETIC ACID IN TREATMENT OF RESISTANCE TO INSULIN, DIABETES MELLITUS TYPE II, HYPERLIPIDEMIA AND HYPERURICEMIA Russian patent published in 2006 - IPC A61K31/192 A61K31/216 A61K31/185 A61K31/165 A61K45/06 A61P3/06 A61P3/10 A61P5/50 A61P9/10 A61P19/06 

Abstract RU 2281762 C2

FIELD: organic chemistry, medicine, endocrinology.

SUBSTANCE: invention relates to improved methods for modulation of diabetes mellitus type II in mammal and modulation of resistance to insulin. Methods involve administration to indicated mammal needing in this treatment of (-)-stereoisomer of compound of the formula (I): wherein R is chosen from group including hydroxy-, lower araloxy-, d-(lower)-alkylamino-(lower)-alkoxy-, (lower)-alkylamido-(lower)-alkoxy-, benzamido-(lower)-alkoxy-, ureido-(lower)-alkoxy-, N'-(lower)-alkyl-ureido-(lower)-alkoxy-, carbamoyl-(lower)-alkoxy-, halophenoxy-substituted lower alkoxy-, carbamoyl-substituted phenoxy-group; or R represents hydrolysable ester group; each X represents independently halogen atom; or its pharmaceutically acceptable salt wherein (-)-stereoisomer doesn't comprise conceptually (+)-stereoisomer. Also, invention relates to pharmaceutical compositions comprising (-)-stereoisomer of compound of the formula (I) and wherein compositions show significantly reduced inhibitory effect on activity of cytochrome P-450 2C9 as compared with racemic composition having 0% enantiomeric excess of (-)-stereoisomer.

EFFECT: valuable medicinal properties of compound and pharmaceutical composition, improved preparing methods.

59 cl, 21 dwg, 8 tbl, 18 ex

Similar patents RU2281762C2

Title Year Author Number
METHOD OF ENHANCING URINATION IN HUMANS 1993
  • Nehnsi M.Grej
RU2139053C1
DERIVATIVES OF OXAZOLE OR THEIR PHARMACEUTICALLY ACCEPTABLE CATION SALTS OR ACID ADDITIVE SALTS 1992
  • Devid Eh.Klark[Us]
RU2079497C1
METHOD FOR TREATING DIABETES 2003
  • Volff Ehndrju
  • Dzherling Markus
RU2320343C2
METHOD OF DIABETES TREATMENT 2007
  • Jerling Markus
  • Vol'Ff Ehndrju
RU2442585C2
N-[2-HYDROXY-3(1-PIPERIDINYL)-PROPOXY]-PYRIDINE-1-OXYDE-3- CARBOXYIMIDOYL CHLORIDE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND TREATMENT METHOD 2000
  • Kjurti Marija
  • Biro Katalin
  • Nad' Karoj
  • Iregdi Laslo
  • Chakai Zita
  • Sil'Bereki Jene
  • Mod'Eroshi Tamash
  • Terek Magdol'Na
  • Komaromi Andrash
  • Marvan'Osh Ehde
  • Barabash Mikhaj
  • Kardosh Mikhajne
  • Nad' Zol'Tan
  • Koran'I Laslo
  • Nad' Melinda
RU2250901C2
TREATMENT OF TYPE I AND II DIABETES 2012
  • Riome Endryu G.
  • Saporito Majkl S.
  • Ochman Aleksandr R.
RU2646475C2
ANTICONVULSIVE DERIVATIVES APPLIED FOR PREVENTING THE DEVELOPMENT OF DIABETES MELLITUS AND SYNDROME X 2001
  • Plata-Salaman Karlos
  • Kruk Dzheffri
RU2268720C2
METHOD OF TREATING HYPERGLYCAEMIA 2017
  • Hsu, Jui-Pao
  • Shane, Guang-Tzuu
  • Lee, Meng-Ju
  • Liao, Yi-Ping
  • Yeh, Yu-Yin
RU2739255C2
APPLICATION OF SIBUTRAMIN ANALOGS FOR PREVENTING DIABETES MELLITUS 1997
  • Behjli Klifford Dzhejms
  • Dzhons Robert Brajn
  • Dzhekson Khelen Kristin
RU2245709C2
NIACIN MIMETICS AND METHOD FOR USE THEREOF 2011
  • Bachovchin Uillyam V.
  • Lej Khung-Sen
  • O'Konnell Deniel
  • U Venen
  • Kiritsi Kristofer P.
RU2588133C2

RU 2 281 762 C2

Authors

Laski Kennet L.

Luo Dzhajn

Dates

2006-08-20Published

2000-06-02Filed